Argatroban for anticoagulation in continuous renal replacement therapy.
about
Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrumsClinical review: use of renal replacement therapies in special groups of ICU patientsRenal replacement therapy in acute kidney injury: controversy and consensusArgatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.Thrombosis prophylaxis in critically ill patients.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician.Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type IISafety and economic considerations of argatroban use in critically ill patients: a retrospective analysisHeparin-induced thrombocytopenia in a non-heparin-naive patient: a case reportArgatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trialThe immobilization of a direct thrombin inhibitor to a polyurethane as a nonthrombogenic surface coating for extracorporeal circulationEfficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy.Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
P2860
Q26799395-7B75E7D1-071B-4B1D-966A-5424C68F800AQ26853350-5F61819E-3240-46FB-BAE0-98D37FA20CF4Q26998864-99553AB9-F193-40AA-BEFE-A2EC24357C28Q33389707-67CBBE00-F236-4377-968F-8BF062BAAC9FQ33394508-26A600E3-7D77-4FFA-B8F0-115420EB9AF6Q33399580-ED147E9A-6C8A-4573-AAD9-82D34B481631Q33402572-3D9DE7EE-5C6C-4166-B0F0-75EF5C26B39AQ33417258-355829EE-BE31-4573-985D-B048E3E81FE5Q33422064-BCC5C114-323E-430C-A712-26DEB7866268Q33425375-534A2C16-A17F-4AD6-822B-90B5BE4F907BQ33427441-D583B9C7-F8B0-434B-B837-2521B519288BQ37119028-C761A580-6028-40AD-BB36-D71B60A773BFQ37962384-586E64A6-DE12-4CA5-944A-806B8BAC6CBFQ50050785-72AC6428-B47C-471F-A0FB-B67306005083
P2860
Argatroban for anticoagulation in continuous renal replacement therapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Argatroban for anticoagulation in continuous renal replacement therapy.
@ast
Argatroban for anticoagulation in continuous renal replacement therapy.
@en
type
label
Argatroban for anticoagulation in continuous renal replacement therapy.
@ast
Argatroban for anticoagulation in continuous renal replacement therapy.
@en
prefLabel
Argatroban for anticoagulation in continuous renal replacement therapy.
@ast
Argatroban for anticoagulation in continuous renal replacement therapy.
@en
P2093
P1476
Argatroban for anticoagulation in continuous renal replacement therapy.
@en
P2093
Alexander Mathes
Andreas Link
Hauke Rensing
Michael Böhm
Simina Selejan
P304
P356
10.1097/CCM.0B013E3181932394
P407
P577
2009-01-01T00:00:00Z